579 related articles for article (PubMed ID: 19697358)
21. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q
ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381
[TBL] [Abstract][Full Text] [Related]
22. Expression of mutant nuclear beta-catenin correlates with non-invasive hepatocellular carcinoma, absence of portal vein spread, and good prognosis.
Mao TL; Chu JS; Jeng YM; Lai PL; Hsu HC
J Pathol; 2001 Jan; 193(1):95-101. PubMed ID: 11169521
[TBL] [Abstract][Full Text] [Related]
23. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.
Yang XR; Xu Y; Yu B; Zhou J; Li JC; Qiu SJ; Shi YH; Wang XY; Dai Z; Shi GM; Wu B; Wu LM; Yang GH; Zhang BH; Qin WX; Fan J
Clin Cancer Res; 2009 Sep; 15(17):5518-27. PubMed ID: 19706825
[TBL] [Abstract][Full Text] [Related]
24. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.
Zhan DQ; Wei S; Liu C; Liang BY; Ji GB; Chen XP; Xiong M; Huang ZY
J Gastroenterol Hepatol; 2012 Jan; 27(1):173-80. PubMed ID: 21777276
[TBL] [Abstract][Full Text] [Related]
25. ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma.
Lin SY; Pan HW; Liu SH; Jeng YM; Hu FC; Peng SY; Lai PL; Hsu HC
Clin Cancer Res; 2008 Aug; 14(15):4814-20. PubMed ID: 18676753
[TBL] [Abstract][Full Text] [Related]
26. Increased expression of Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma.
Yang LY; Tao YM; Ou DP; Wang W; Chang ZG; Wu F
Clin Cancer Res; 2006 Oct; 12(19):5673-9. PubMed ID: 17020969
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological implications of immunohistochemically demonstrated mucin core protein expression in hepatocellular carcinoma.
Ichikawa T; Yamamoto T; Uenishi T; Tanaka H; Takemura S; Ogawa M; Tanaka S; Suehiro S; Hirohashi K; Kubo S
J Hepatobiliary Pancreat Surg; 2006; 13(3):245-51. PubMed ID: 16708303
[TBL] [Abstract][Full Text] [Related]
28. Spindle cell hepatocellular carcinoma. A clinicopathologic and immunohistochemical analysis of 15 cases.
Maeda T; Adachi E; Kajiyama K; Takenaka K; Sugimachi K; Tsuneyoshi M
Cancer; 1996 Jan; 77(1):51-7. PubMed ID: 8630939
[TBL] [Abstract][Full Text] [Related]
29. Angiopoietin-2 levels in the hepatic vein as a useful predictor of tumor invasiveness and prognosis in human hepatocellular carcinoma.
Kuboki S; Shimizu H; Mitsuhashi N; Kusashio K; Kimura F; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Miyazaki M
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e157-64. PubMed ID: 17931370
[TBL] [Abstract][Full Text] [Related]
30. Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma.
Yuan RH; Jeng YM; Chen HL; Lai PL; Pan HW; Hsieh FJ; Lin CY; Lee PH; Hsu HC
J Pathol; 2006 Aug; 209(4):549-58. PubMed ID: 16739096
[TBL] [Abstract][Full Text] [Related]
31. Tissue factor is a useful prognostic factor of recurrence in hepatocellular carcinoma in 5-year survivors.
Kaido T; Oe H; Yoshikawa A; Mori A; Arii S; Imamura M
Hepatogastroenterology; 2005; 52(65):1383-7. PubMed ID: 16201079
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of tumor-infiltrating FOXP3+ regulatory T cells in patients with hepatocellular carcinoma.
Sasaki A; Tanaka F; Mimori K; Inoue H; Kai S; Shibata K; Ohta M; Kitano S; Mori M
Eur J Surg Oncol; 2008 Feb; 34(2):173-9. PubMed ID: 17928188
[TBL] [Abstract][Full Text] [Related]
33. Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection.
Yang XR; Xu Y; Shi GM; Fan J; Zhou J; Ji Y; Sun HC; Qiu SJ; Yu B; Gao Q; He YZ; Qin WZ; Chen RX; Yang GH; Wu B; Lu Q; Wu ZQ; Tang ZY
Clin Cancer Res; 2008 Jun; 14(12):3850-9. PubMed ID: 18559605
[TBL] [Abstract][Full Text] [Related]
34. N-myc downstream regulated gene 1 (NDRG1)/Cap43 enhances portal vein invasion and intrahepatic metastasis in human hepatocellular carcinoma.
Akiba J; Ogasawara S; Kawahara A; Nishida N; Sanada S; Moriya F; Kuwano M; Nakashima O; Yano H
Oncol Rep; 2008 Dec; 20(6):1329-35. PubMed ID: 19020710
[TBL] [Abstract][Full Text] [Related]
35. Importin-α1 as a novel prognostic target for hepatocellular carcinoma.
Yoshitake K; Tanaka S; Mogushi K; Aihara A; Murakata A; Matsumura S; Mitsunori Y; Yasen M; Ban D; Noguchi N; Irie T; Kudo A; Nakamura N; Tanaka H; Arii S
Ann Surg Oncol; 2011 Jul; 18(7):2093-103. PubMed ID: 21286940
[TBL] [Abstract][Full Text] [Related]
36. Better survival in women with resected hepatocellular carcinoma is not related to tumor proliferation or expression of hormone receptors.
Ng IO; Ng M; Fan ST
Am J Gastroenterol; 1997 Aug; 92(8):1355-8. PubMed ID: 9260806
[TBL] [Abstract][Full Text] [Related]
37. Predictors of hepatic venous trunk invasion and prognostic factors in patients with hepatocellular carcinomas that had come into contact with the trunk of major hepatic veins.
Matsuda M; Suzuki T; Kono H; Fujii H
J Hepatobiliary Pancreat Surg; 2007; 14(3):289-96. PubMed ID: 17520205
[TBL] [Abstract][Full Text] [Related]
38. Expression of vascular endothelial growth factor-C in human hepatocellular carcinoma.
Yamaguchi R; Yano H; Nakashima O; Akiba J; Nishida N; Kurogi M; Kojiro M
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):152-60. PubMed ID: 16706827
[TBL] [Abstract][Full Text] [Related]
39. Proline-directed protein kinase FA is a powerful and independent prognostic predictor for progression and patient survival of hepatocellular carcinoma.
Hsu YC; Fu HH; Jeng YM; Lee PH; Yang SD
J Clin Oncol; 2006 Aug; 24(23):3780-8. PubMed ID: 16754939
[TBL] [Abstract][Full Text] [Related]
40. [Correlation of NY-ESO-1 gene and protein expression to metastasis and clinicopathologic features of hepatocellular carcinoma].
Zhang WM; Xiao G; Xie D; Zhang M; Guo AL; Wen JM
Ai Zheng; 2005 May; 24(5):622-6. PubMed ID: 15890110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
